News | January 07, 2024
Pharmaids Pharmaceuticals to acquire Adita Bio Sys in share swap
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
The deal includes upfront payments, milestone payments and ongoing royalties
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Comprehensive clinical development programs being initiated for each investigational candidate
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
Subscribe To Our Newsletter & Stay Updated
